Emergency/Compassionate Use - Muscular VSD Occluder
- Conditions
- VentricularVSDSeptalDefectsMuscular
- Registration Number
- NCT00590382
- Lead Sponsor
- Abbott Medical Devices
- Brief Summary
Expanded access to the AMPLATZER Muscular VSD Occluder
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- APPROVED_FOR_MARKETING
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Emergency/compassionate use for patients not meeting the inclusion criteria for the AMPLATZER Muscular VSD clinical trial
Exclusion Criteria
Not provided
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of the AMPLATZER Muscular VSD Occluder in repairing ventricular septal defects?
How does the AMPLATZER Muscular VSD Occluder compare to surgical patch repair in managing congenital heart defects?
What biomarkers are used to identify patients most likely to benefit from AMPLATZER VSD occlusion therapy?
What are the potential adverse events associated with AMPLATZER VSD occluder implantation and their management strategies?
Are there any combination therapies or competitor devices for treating muscular ventricular septal defects in pediatric cardiology?